Shares in Chugai Pharmaceutical, Japan's largest drugmaker, have tumbled the most since 1977 after late-stage trial data on an obesity drug it licensed to Eli Lilly & Co. showed disappointing results. https://www.japantimes.co.jp/business/2025/08/08/companies/chugai-shares-sink/?utm_medium=Social&utm_source=mastodon #business #companies #chugai #health #pharmaceuticals #obesity
A team of researchers in Japan found a key biological component that may help explain why women tend to burn more calories from fat than men, which could help lead to new treatments for obesity and related diseases. https://www.japantimes.co.jp/news/2025/07/15/japan/science-health/japan-research-women-metabolism/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #health #instituteofsciencetokyo #universityoftokyo #obesity
"Simplistic notions based on 'energy in and energy out' have proven largely ineffective both when dealing with individuals and with populations. This might be owing to the fact that current interventions do not take into account the complex biopsychological responses to defend body weight or the notion that only overconsumption of food and physical inactivity are the root causes of obesity."
Jean-Philippe Chaput, 2014
https://pmc.ncbi.nlm.nih.gov/articles/PMC4229150/
(1/2)